PEAK6 Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | $2.69M | Buy |
21,645
+6,446
| +42% | +$800K | 0.01% | 200 |
|
|
2018
Q1 | $1.69M | Sell |
15,199
-4,804
| -24% | -$535K | 0.01% | 338 |
|
|
2017
Q4 | $2.39M | Buy |
20,003
+3,744
| +23% | +$448K | 0.01% | 236 |
|
|
2017
Q3 | $2.28M | Sell |
16,259
-58,596
| -78% | -$8.22M | 0.01% | 214 |
|
|
2017
Q2 | $9.11M | Buy |
74,855
+57,784
| +338% | +$7.03M | 0.05% | 59 |
|
|
2017
Q1 | $2.07M | Buy |
+17,071
| New | +$2.07M | 0.02% | 228 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 2017 |
|
|
2016
Q3 | – | Sell |
-19,592
| Closed | -$2.29M | – | 1892 |
|
|
2016
Q2 | $2.29M | Buy |
+19,592
| New | +$2.29M | 0.02% | 161 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 2008 |
|
|
2015
Q4 | – | Sell |
-31,920
| Closed | -$4.99M | – | 2088 |
|
|
2015
Q3 | $4.99M | Buy |
31,920
+13,679
| +75% | +$2.14M | 0.03% | 161 |
|
|
2015
Q2 | $3.3M | Sell |
18,241
-8,064
| -31% | -$1.46M | 0.02% | 215 |
|
|
2015
Q1 | $4.56M | Buy |
26,305
+16,991
| +182% | +$2.94M | 0.03% | 128 |
|
|
2014
Q4 | $1.72M | Sell |
9,314
-25,610
| -73% | -$4.74M | 0.01% | 313 |
|
|
2014
Q3 | $5.79M | Buy |
34,924
+14,406
| +70% | +$2.39M | 0.04% | 169 |
|
|
2014
Q2 | $3.21M | Sell |
20,518
-19,492
| -49% | -$3.05M | 0.03% | 197 |
|
|
2014
Q1 | $6.09M | Buy |
40,010
+37,747
| +1,668% | +$5.74M | 0.05% | 145 |
|
|
2013
Q4 | $301K | Sell |
2,263
-34,663
| -94% | -$4.61M | ﹤0.01% | 860 |
|
|
2013
Q3 | $2.15M | Buy |
36,926
+31,226
| +548% | +$1.82M | 0.01% | 353 |
|
|
2013
Q2 | $526 | Buy |
+5,700
| New | +$526 | ﹤0.01% | 643 |
|